Three young DZNE researchers receive Alzheimer Doctoral Scholarships from the Hans and Ilse Breuer Foundation
In order to support young researchers in the field of dementia research in Germany,…
DZG statement on the Russian invasion of Ukraine
We, the German Centers for Health Research (DZG), consider the Russian invasion of Ukraine an attack on elementary values of freedom, democracy and…
DZNE scientist Patrick Weydt is a guest in the current "ALS Podcast" of the Charité
DZNE researcher PD Dr. Patrick Weydt is a guest on the current "ALS Podcast" of Charité - Universitätsmedizin…
Prof. Joachim Schultze as a guest on "Campus Talks" on ARD-alpha
Editor's tip: Prof. Joachim Schultze, Director Systems Medicine at the DZNE and Professor for Genomics and Immunoregulation at…
A European research consortium led by DZNE will be investigating the neurodegenerative disease “Spinocerebellar Ataxia Type 3” (SCA3) in collaboration with the French pharmaceutical company Servier…
Long-term Benzodiazepine Use Attacks Synapses
Benzodiazepines are effective and widely used drugs for treating states of anxiety and sleep disorders. While short-term treatments are considered…
In individuals with a genetic predisposition to Alzheimer’s disease, the immune cells of the brain – the “microglia” – start exerting a protective effect up to two decades before the first symptoms…
A study by DZNE and the University Hospital Bonn suggests that assessments of the eye’s retina could help to detect a loss of brain substance, i. e. “brain atrophy”.
Bonn, March 15, 2022. Researchers…
Virtual reality against memory loss
Preventing cognitive decline in old age requires scientific training approaches that can be conducted autonomously from home. In our research we have focused on…
Frontotemporal dementia: Prof. Manuela Neumann receives Alzheimer Research Initiative funding
Pathologically altered proteins in the central nervous system are a common feature of many…
